Clinical Stage | ||||
I | 1# | 8.09# | 26.35# | 16.67# |
II | 18 | 7.68 (5.68 - 9.02) | 24.68 (16.78 - 35.04) | 17.75 (8.73 - 26.05) |
III | 11 | 7.17 (6.06 - 9.02) | 21.53 (17.22 - 36.35) | 16.38 (7.15 - 23.28) |
IV | 30 | 12.58 (9.14 - 27.10) | 111.04 (38.09 - 302) | 39.04 (7.02 - 174.23) |
H(p) |
| 60 (<0.001)* | 60 (<0.001)* | 1.22 (0.747) |
Vascular Invasion | ||||
Negative | 2 | 9.35 (9.22 - 9.49) | 45.26 (42.0 - 48.52) | 23.39 (17.65 - 29.13) |
Positive | 28 | 10.07 (5.68 - 27.10) | 68.07 (16.78 - 302) | 28.29 (7.02 - 174.23) |
U(p) |
| 52.0 (0.824) | 52.0 (0.824) | 42.0 (0.547) |
Site of Metastasis | ||||
Bone | 9 | 14.64 (9.02 - 18.49) | 146.40 (36.35 - 257.22) | 48.02 (7.43 - 105.01) |
Lung | 8 | 12.62 (9.49 - 15.94) | 117.92 (48.52 - 253.30) | 37.06 (7.02 - 56.34_ |
Liver | 6 | 12.29 (9.23 - 15.94) | 108.30 (46.35 - 253.30) | 43.98 (14.13 - 95.76) |
Other sites | 7 | 10.17 (9.22 - 81.57) | 60.07 (42 - 81.57) | 25.55 (7.02 - 81.56) |
H(p) |
| 7.91 (0.048)* | 7.05 (0.070) | 4.70 (0.195) |